Upload Avatar (500 x 500)
Weimin Cai
weimincai@fudan.edu.cn
Chinese, English
Shanghai
Fudan University
Pharmaceutical Sciences
  • 1978.09 – 1982.07 Bachelor in Pharmacy: Second Military Medical University, Shanghai
  • 1983.01 – 1985.12 Master in Medicine: Second Military Medical University, Shanghai
  • 1997.09 – 2000.07 PhD in Pharmacology: Nanjing Medical University
  • 1986.07 – 2003.03 Nanjing General Hospital of Nanjing Military Region - Clinical Pharmacologist, Deputy Director
  • 1992.10 – 1994.10 University of Kentucky College of Pharmacy - Visiting Scholar (Clinical Pharmacy)
  • 2000.10 – 2001.10 University of Kentucky College of Pharmacy - Postdoctoral Researcher (Genetic Pharmacology)
  • 2003.04 – 2008.05 Ruijin Hospital, Shanghai Jiao Tong University School of Medicine - Director of Pharmacy Department, Chief Pharmacist, Doctoral Supervisor
  • 2008.06 – 2019.10 Fudan University School of Pharmacy - Director of Clinical Pharmacy and Pharmacy Management Department
  • 2008.06 – Present Fudan University School of Pharmacy - Professor, Doctoral Supervisor
  • Military Science and Technology Progress Award Second Prize (1991): Second Contributor
  • Military Science and Technology Progress Award Second Prize (1997): First Contributor
  • Military Science and Technology Progress Award Second Prize (2001): First Contributor
  • National Excellent Doctoral Dissertation Award (2002)
  • Nanjing Military Region Science and Technology Talent Award (2003)
  • Jiangsu Province Science and Technology Progress Third Prize (2003): Second Contributor
  • Shanghai Pharmaceutical Science and Technology Third Prize (2007): First Contributor
Pharmacogenomics and Personalized Medicine
Clinical Pharmacokinetics and Pharmacodynamics
Therapeutic Drug Monitoring
  • Determination of S-propargyl-cysteine in rat plasma by mixed-mode reversed-phase and cation-exchange HPLC-MS/MS method and its application to pharmacokinetic studies, Weimin Cai, 2011
  • High incidence of severe neutropenia after gemcitabine-based chemotherapy in Chinese cancer patients with CDA 79A>C mutation, Weimin Cai, 2012
  • Influence of genetic and non-genetic factors on the plasma concentrations of the clopidogrel metabolite (SR26334) among Chinese patients, Weimin Cai, 2013
  • Encapsulation of liver microsomes into a thermosensitive hydrogel for characterization of drug metabolism and toxicity, Weimin Cai, 2013
  • 美国Pharm.D.教育及其对我国临床药学教育的启示, Weimin Cai, 2013
  • 种族敏感性临床试验的样本量计算方式探讨, Weimin Cai, 2014
  • Physicochemical characteristics and gastrointestinal absorption behaviors of S-propargyl-cysteine, a potential new drug candidate for cardiovascular protection and antitumor treatment, Weimin Cai, 2015
Pharmacogenomics Personalized Medicine Genetic Polymorphism Drug Metabolism Clinical Pharmacokinetics Pharmacodynamics Therapeutic Drug Monitoring End-Stage Renal Disease Drug Resistance Cancer Pharmacology

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.